Does therapy of the primary tumor matter in oligometastatic prostate cancer? A prospective 10-year follow-up study.

ABSTRACT: Objective: The effect of curative treatment for oligometastatic prostate cancer patients is unsolved, both with regard to morbidity and mortality. With this study, we provide some of the first long-term follow-up data on progression and mortality in oligometastatic prostate cancer patients after curative treatment of their primary tumor. Methods: A cohort of 210 patients with diagnosed prostate cancer was established between 2008 and 2010. All patients were scheduled for intended curative treatment, and all underwent blinded ¹⁸F-choline positron-emission tomography/computed tomography at inclusion prior to curative treatment. Upon unblinding, 12 patients (6%) were recategorized as being oligometastatic. They had a mean age of 64 years, median prostate-specific anti

SUBMITTER: Poulsen MH 

PROVIDER: S-EPMC6679689 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature